Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells

International Journal of Oncology

Volumn 44, Issue 5, 2014, Pages 1529-1538

  Sweeney, Elizabeth E ^a   Fan, Ping ^a   Jordan, V Craig ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Estrogen deprivation; Glutathione; Insulin like growth factor receptor; Oxidative stress

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; GLUTATHIONE; HEME OXYGENASE 1; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN C RECEPTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CLONE; CELL SURVIVAL; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; HUMAN CELL; MCF 7 CELL LINE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899046603     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2329     Document Type: Article

References (19)

1. Sweeney EE, McDaniel RE, Maximov PY, Fan P and Jordan VC: Models and mechanisms of acquired resistance in breast cancer: Significant clinical progress despite limitations. Hom Mol Biol Clin Investig 9: 143-163, 2012.
2. Jiang SY, Wolf DM, Yingling JM, Chang C and Jordan VC: An estrogen receptor positive MCF-7 clone that is resistant to anti-estrogens and estradiol. Mol Cell Endocrinol 90: 77-86, 1992.
3. Lewis JS, Osipo C, Meeke K and Jordan VC: Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal. J Steroid Biochem Mol Biol 94: 131-141, 2005. (Pubitemid 40614526)
4. Pink JJ, Jiang SY, Fritsch M and Jordan VC: An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein. Cancer Res 55: 2583-2590, 1995.
5. Pink JJ and Jordan VC: Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321-2330, 1996. (Pubitemid 26154081)
6. Pink JJ, Wu SQ, Wolf DM, Bilimoria MM and Jordan VC: A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7. Nucleic Acids Res 24: 962-969, 1996. (Pubitemid 26076204)
7. Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Changel NS and Jordan VC: Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst 97: 1746-1759, 2005. (Pubitemid 41782284)
8. Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim HR, Yerrum S, Sharma CG, Nicolas E, Balagurunathan Y, Ross EA and Jordan VC: Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci USA 108: 18879-18886, 2011.
9. Fan P, Griffith OL, Agboke FA, Anur P, Zou X, McDaniel RE, Creswell K, Kim SH, Katzenellenbogen JA, Gray JW and Jordan VC: c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells. Cancer Res 73: 4510-4520, 2013.
10. Ellis MJ, Gao F, Dehdashti F, Jeffe DB, Marcom PK, Carey LA, Dickler MN, Silverman P, Fleming GF, Kommareddy A, Jamalabadi-Majidi S, Crowder R and Siegel BA: Lower-dose vs high-dose oral estradiol therapy of hormone receptor positive, aromatase inhibitor resistant advanced breast cancer: A Phase 2 randomized study. JAMA 302: 774-780, 2009.
11. Fan P, McDaniel RM, Kim HR, Clagett D, Haddad B and Jordan VC: Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines. Eur J Cancer 48: 3488?3498, 2012.
12. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R and Wassertheil-Smoller S; Women's Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 291: 1701-1712, 2004. (Pubitemid 38489892)
13. Doroshow JH: Glutathione peroxidase and oxidative stress. Toxicol Lett 82-83: 395-398, 1995.
14. Siemankowski LM, Morreale J and Briehl MM: Antioxidant defenses in the TNF-treated MCF-7 cells: selective increase in MnSOD. Free Radic Biol Med 26: 919-924, 1999. (Pubitemid 29198364)
15. Lee YJ, Chen JC, Amoscato AA, Bennouna J, Spitz DR, Suntharalingam M and Rhee JG: Protective role of Bcl2 in metabolic oxidative stress-induced cell death. J Cell Sci 114: 677-684, 2001.
16. Brodie A, Macedo L and Sabnis G: Aromatase resistance mechanisms in model systems in vivo. J Steroid Biochem Mol Biol 118: 283-287, 2010.
17. Fox EM, Miller TW, Balko JM, Kuba MG, Sanchez V, Smith RA, Liu S, Gonzalez-Angulo AM, Mills GB, Ye F, Shyr Y, Manning HC, Buck E and Arteaga CL: A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. Cancer Res 71: 6773-6784, 2011.
18. Osborne CK and Schiff R: Mechanisms of endocrine resistance in breast cancer. Annu Rev Med 62: 233-247, 2011.
19. Lee JY, Han CY, Yang JW, Smith C, Kim SK, Lee EY, Kim SG and Kang KW: Induction of glutathione transferase in insulin?like growth factor type I receptor-overexpressed hepatoma cells. Mol Pharmacol 72: 1082-1093, 2007. (Pubitemid 47481431)